BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37071773)

  • 21. Malignant peripheral nerve sheath tumour of the oral and maxillofacial region-A systematic review.
    Schuch LF; Kirschnick LB; de Arruda JAA; Klein IP; Silveira FM; Vasconcelos ACU; Santos-Silva AR; Lopes MA; Carrard VC; Vargas PA; Martins MAT; Wagner VP; Martins MD
    Oral Dis; 2022 Nov; 28(8):2072-2082. PubMed ID: 34333825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
    Carlson ML; Jacob JT; Habermann EB; Glasgow AE; Raghunathan A; Link MJ
    J Neurosurg; 2016 Nov; 125(5):1120-1129. PubMed ID: 26745487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience of a single center in the treatment of rare malignant peripheral nerve sheath tumors during the years 1991-2021.
    Ptchelintseva A; Nuutinen H; Salo J; Tukiainen E
    J Plast Surg Hand Surg; 2023; 57(1-6):376-382. PubMed ID: 36244030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant peripheral nerve sheath tumours associated with von Recklinghausen's neurofibromatosis.
    Ramanathan RC; Thomas JM
    Eur J Surg Oncol; 1999 Apr; 25(2):190-3. PubMed ID: 10218464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
    Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
    PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.
    Miao R; Wang H; Jacobson A; Lietz AP; Choy E; Raskin KA; Schwab JH; Deshpande V; Nielsen GP; DeLaney TF; Cote GM; Hornicek FJ; Chen YE
    Radiother Oncol; 2019 Aug; 137():61-70. PubMed ID: 31078939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience.
    Sobczuk P; Teterycz P; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Kozak K; Falkowski S; Goryń T; Zdzienicki M; Morysiński T; Rutkowski P
    Surg Oncol; 2020 Dec; 35():276-284. PubMed ID: 32949967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.
    Lim Z; Gu TY; Tai BC; Puhaindran ME
    World J Surg Oncol; 2024 Jan; 22(1):14. PubMed ID: 38191386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
    Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
    Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
    Vasconcelos RAT; Guimarães Coscarelli P; Vieira TM; Noguera WS; Rapozo DCM; Acioly MA
    Cancer Med; 2019 Mar; 8(3):972-981. PubMed ID: 30735009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant Peripheral Nerve Sheath Tumor of the Cervix.
    Zhang T; Wang Z; Wang R; Wu X; Zhao M; Su F
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):S24-S27. PubMed ID: 35633002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
    Friedrich RE; Hartmann M; Mautner VF
    Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Jones J; Cain S; Pesic-Smith J; Choong PFM; Morokoff AP; Drummond KJ; Dabscheck G
    J Neurooncol; 2021 Sep; 154(3):265-274. PubMed ID: 34529228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.
    Zehou O; Fabre E; Zelek L; Sbidian E; Ortonne N; Banu E; Wolkenstein P; Valeyrie-Allanore L
    Orphanet J Rare Dis; 2013 Aug; 8():127. PubMed ID: 23972085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.
    Moretti VM; Crawford EA; Staddon AP; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2011 Aug; 34(4):417-21. PubMed ID: 20838322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.
    Miller DT; Cortés-Ciriano I; Pillay N; Hirbe AC; Snuderl M; Bui MM; Piculell K; Al-Ibraheemi A; Dickson BC; Hart J; Jones K; Jordan JT; Kim RH; Lindsay D; Nishida Y; Ullrich NJ; Wang X; Park PJ; Flanagan AM
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32252413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superficial or cutaneous malignant peripheral nerve sheath tumor--clinical experience at Taipei Veterans General Hospital.
    Feng CJ; Ma H; Liao WC
    Ann Plast Surg; 2015 May; 74 Suppl 2():S85-8. PubMed ID: 25695445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implications of intradural extension in paraspinal malignant peripheral nerve sheath tumors: effects on central nervous system metastases and overall survival.
    Gilder HE; Puffer RC; Bydon M; Spinner RJ
    J Neurosurg Spine; 2018 Dec; 29(6):725-728. PubMed ID: 30239270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.